(-)-Catechin

CAS No. 18829-70-4

(-)-Catechin( —— )

Catalog No. M33207 CAS No. 18829-70-4

(-)-Catechin ((-)-Cianidanol), an isomer of catechin, inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 92 In Stock
5MG 92 In Stock
10MG 180 In Stock
25MG 377 In Stock
50MG 548 In Stock
100MG 784 In Stock
200MG Get Quote In Stock
500MG 1609 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    (-)-Catechin
  • Note
    Research use only, not for human use.
  • Brief Description
    (-)-Catechin ((-)-Cianidanol), an isomer of catechin, inhibits cyclooxygenase-1 (COX-1) with an IC50 of 1.4 μM.
  • Description
    (-)-Catechin is Catechin's one kind of different structure. Catechin inhibitory enzyme-1 (COX-1), IC50 为 1.4 μM. (-)-Catechin promotes hBM-MSC adipose cell differentiation, increases fat cell differentiation, and PPARγ level.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Chromatin/Epigenetic
  • Target
    COX
  • Recptor
    COX
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    18829-70-4
  • Formula Weight
    290.27
  • Molecular Formula
    C15H14O6
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (430.63 mM; Ultrasonic (<60°C)
  • SMILES
    O[C@@H]1Cc2c(O)cc(O)cc2O[C@H]1c1ccc(O)c(O)c1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Waffo-Téguo P, et al. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures. Nutr Cancer. 2001;40(2):173-9.?
molnova catalog
related products
  • Nifenazone

    Nifenazone is a drug that has been used as an analgesic for a number of rheumatic conditions.

  • Resveratrol

    Resveratrol is a phytoalexin produced naturally by several plants with anti-Y, anti-inflammatory, blood-sugar-lowering and other beneficial cardiovascular effects.

  • Emapalumab

    Emapalumab (NI-0501) is an IgG1 monoclonal antibody that humanizes human monoclonal antibodies against interferon gamma, blocking its binding to cell surface receptors and activating inflammatory signaling.